“…When the multivariable model adjusted for age, ECOG performance status, ASA level, FIGO stage, ascites, RD, and histology was applied to the 689 women who received chemotherapy, superficial SSI remained an independent predictor of worse OS (adjusted HR 1.70, 95% CI 1.06, 2.73) and there was a trend toward worse OS associated with organ/ space SSI (adjusted HR 1.39, 95% CI 0.95, 2.04). The median number of days from surgery to adjuvant chemotherapy (TTC) was significantly less in those without SSI prior to starting chemotherapy compared to the women who had a SSI prior to starting chemotherapy (median (IQR) 31 (27,41) vs. 44 (36, 52) days, P b 0.001). The following factors were identified in a multivariable analysis as being significantly (P b 0.05) associated with TTC: age, ascites, surgical complexity and estimated blood loss.…”